Aldeyra Therapeutics, Inc. Share Price
NASDAQ: ALDX | Micro CapAldeyra Therapeutics, Inc. Stock Performance
Open $1.55 | Prev. Close $1.54 | Circuit Range N/A |
Day Range $1.49 - $1.55 | Year Range $1.07 - $6.16 | Volume 23,875 |
Average Traded $1.51 |
Aldeyra Therapeutics, Inc. Share Price Today
As of 29 August 2026, Aldeyra Therapeutics, Inc.'s share price is $1.48. The stock opened at $1.55, compared to its previous close of $1.54. During today's trading session, Aldeyra Therapeutics, Inc.'s share price traded between $1.49 and $1.55, with an average price of $1.52. Over the past 52 weeks, the stock has recorded a high of $6.16 and a low of $1.07. In terms of performance, Aldeyra Therapeutics, Inc.'s share price has declined by 72.94% over the last six months and is down 74.66% on a year-on-year basis.
Aldeyra Therapeutics, Inc. Share Price Chart
Aldeyra Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $88.88M | PE Ratio (TTM) -2.64 | Dividend Yield N/A |
EPS (TTM) $-0.56 | Revenue (TTM) N/A | Return On Equity (TTM) -76.49% |
Profit Margin N/A | Debt to Equity 0.63 | Quarterly Earnings Growth YoY 49.13% |
Aldeyra Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Aldeyra Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platform, including ADX 248, ADX 743, ADX 631, ADX 246, and other product candidates in development for inflammatory and metabolic diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
Aldeyra Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.50 | $1.55 | +0.65% |
Jul 2026 | $2.16 | $1.54 | -28.04% |
Jun 2026 | $1.73 | $2.14 | +22.99% |
May 2026 | $1.52 | $1.74 | +14.47% |
Apr 2026 | $1.75 | $1.52 | -10.59% |
Mar 2026 | $5.52 | $1.70 | -68.92% |
Feb 2026 | $5.34 | $5.47 | +2.05% |
Jan 2026 | $5.08 | $5.36 | +3.47% |
Dec 2025 | $5.39 | $5.18 | -5.56% |
Nov 2025 | $5.12 | $5.49 | +8.08% |
Oct 2025 | $5.27 | $5.08 | -2.68% |
Sep 2025 | $5.89 | $5.21 | -10.70% |
ALDX Share Price FAQs
What is Aldeyra Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Aldeyra Therapeutics, Inc. stock?
What is ALDX's market capitalisation today?
What is ALDX's net income for the last quarter?
What is the 5 year returns of ALDX?
What is the high & low stock price of ALDX today?
Can I buy ALDX shares in India?